Study and Monitoring of Multiple Endocrine Neoplasia Type 1
Condition(s):MEN1Last Updated:November 18, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):MEN1Last Updated:November 18, 2023Recruiting
Condition(s):Multiple Endocrine NeoplasiaLast Updated:November 21, 2017Recruiting
Condition(s):Multiple Endocrine Neoplasia Type 1; Pancreatic Neuroendocrine TumorLast Updated:September 27, 2022Recruiting
Condition(s):Neuroendocrine Tumor of Pancreas; Multiple Endocrine Neoplasia Type 1Last Updated:December 1, 2023Recruiting
Condition(s):Pancreatic Neuroendocrine Tumors in MEN1Last Updated:April 8, 2019Not yet recruiting
Condition(s):Multiple Endocrine NeoplasiaLast Updated:May 23, 2019Recruiting
Condition(s):Multiple Endocrine Neoplasia Type 1 (MEN-1); Thymic CarcinoidLast Updated:September 30, 2021Completed
Condition(s):MEN1 Gene MutationLast Updated:June 2, 2023Recruiting
Condition(s):Multiple Endocrine Neoplasia Type 1; Pancreatic Neuroendocrine CarcinomaLast Updated:March 23, 2020Completed
Condition(s):Type 1-Multiple Endocrine Neoplasia SyndromeLast Updated:August 25, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.